A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
about
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?The role of autophagy in Parkinson's diseasePale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synucleinUCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration.Modelling the role of UCH-L1 on protein aggregation in age-related neurodegeneration.A transcriptome analysis of mitten crab testes (Eriocheir sinensis).Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals.An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegenerationDistinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.The computational analysis of human testis transcriptome reveals closer ties to pluripotencyα-Synuclein oligomers and clinical implications for Parkinson disease.Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.Gene expression profiling of mesenteric lymph nodes from sheep with natural scrapie.Neurodegenerative disorders and nanoformulated drug development.Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration.Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders.Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?Clinicopathological correlates of lewy body disease: fundamental issues.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseA mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration.Delaying aging is neuroprotective in Parkinson's disease: a genetic analysis in C. elegans models.Proteasome inhibition in medaka brain induces the features of Parkinson's disease.Biological Implications of Differential Expression of Mitochondrial-Shaping Proteins in Parkinson's Disease.Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain.A new F-box protein 7 gene mutation causing typical Parkinson's disease.Analysis of blood-based gene expression in idiopathic Parkinson disease.Salidroside Promotes the Pathological α-Synuclein Clearance Through Ubiquitin-Proteasome System in SH-SY5Y Cells.27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons.
P2860
Q26752685-995734CE-5AF1-40D5-BFBE-2B20A032F766Q26796638-5B80AF8A-6FC8-4B4D-A371-A5B38D21F93BQ27023788-10410EB4-FE46-41FD-9959-D8C16D802936Q28585769-BFA1056E-E09B-44EE-B34E-A44F2FBF18E0Q31077544-56FFD412-9685-445C-97E5-7A5885A0280FQ33508801-8E80B495-2E0F-4D19-A421-865264719DEAQ33719548-330518F7-058E-4BE4-ABBE-DDED096CE017Q33920906-2238949D-117D-4358-88EE-A59B3C9A6468Q34994326-6E80DBF3-1894-4B15-ABEE-74CEA24ACFFBQ35057159-AB049C0A-291C-4BE9-86B3-42EE9DABA921Q35911798-8AF367AC-EFA5-4A8C-A24B-37F3C9141B99Q36653589-69C1A62F-88BC-4C28-82D7-98E616DF211BQ36706494-1E7A22D7-9C5E-424B-BEC1-64C2C52A3205Q36718306-955C79FD-9672-426F-8D61-5E76CC76E2ADQ36985668-B0AF0AE7-4489-4AEA-9A49-86291AF2605EQ37272000-2CC54419-DB8D-40EE-B734-44DEABE0A152Q37529488-919C23FF-D88F-440A-8930-5A1DEDD8F845Q37538771-4507C26D-D59B-4D88-B0FC-AFBAE55CA198Q37702453-4D76CA49-60FD-49CF-A60A-DC4BE81B746EQ37744753-70FD86DB-B806-4E14-824F-3ED975DEE484Q38021661-93550F43-461A-4615-B615-372AD62F2E6AQ38215509-E88F5A10-6C6A-4A8E-BEA1-C55126338B41Q39205712-6C9C9902-F24C-4252-938E-B0A167D25248Q39407652-88B9C961-2BF0-4F33-8E11-C62751540FF1Q41055590-8EC2AEFA-16FD-4CEA-8773-0387210E352EQ42962546-9D80D73B-D9D9-44C9-8743-9252AF11B0E9Q47265377-FD01AA16-D209-4F4F-A737-7B2F0AEF70C9Q47348189-FD8E2384-65B7-45E0-AC61-E34A6B164312Q47746629-707F6670-AF2F-492B-B2FD-F4C1446AE4B7Q47970486-4DEE1A5C-E5AF-4629-A22C-16BF2147BB6EQ47976347-AFDE32BE-4F6D-4E09-BFD7-9FB0FF6000C4Q55080796-3A593B4A-9082-4A3E-AADE-1911D9CEDBEBQ55236585-FE16817B-9343-415A-80F2-6F698463ECEF
P2860
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
@en
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
@nl
type
label
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
@en
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
@nl
altLabel
A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease
@en
prefLabel
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
@en
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
@nl
P2860
P1476
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
@en
P2093
Casey Cook
P2860
P304
P356
10.1016/J.BBADIS.2009.01.012
P407
P577
2009-02-03T00:00:00Z